Market Cap

Aytu BioScience, Inc. Market Capitalization:

$15.2 Million

USD as of Jan. 1, 2024

business Aytu BioScience, Inc. Company Profile

Aytu BioScience, Inc. Main Stock Listing

NASDAQ: AYTU

Market Capitalization History of Aytu BioScience, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $622.07 B
Vertex Pharmaceuticals Incorporated $121.36 B
Regeneron Pharmaceuticals, Inc. $115.11 B
CSL Limited $95.75 B
Marinomed Biotech AG $75.67 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of Aytu BioScience, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2024 $15.2 M 27.72%
Jan. 1, 2023 $11.9 M 170.23%
Jan. 1, 2022 $4.4 M -81.65%
Jan. 1, 2021 $24.0 M -0.83%
Jan. 1, 2020 $24.2 M -38.98%
Jan. 1, 2019 $39.7 M -97.97%
Jan. 1, 2018 $1.96 B -85.87%
Jan. 1, 2017 $13.85 B -90.96%
Jan. 1, 2016 $153.29 B -68.84%
Jan. 1, 2015 $491.94 B -28.57%
Jan. 1, 2014 $688.71 B -50.00%
Jan. 1, 2013 $1.377 T 100.00%
Jan. 1, 2012 $688.71 B 40.00%
Jan. 1, 2011 $491.94 B -48.98%
Jan. 1, 2010 $964.20 B -3.92%
Jan. 1, 2009 $1.004 T

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Aytu BioScience, Inc. Categories

United States languages Healthcare languages Biotechnology
United States Healthcare United States Biotechnology

Stocks & Indices

Aytu BioScience, Inc. has the following listings and related stock indices.


Stock: NASDAQ: AYTU

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.